Are patients interested in pharmaceutical research?
It is important to involve patients and the public in pharmaceutical medicines research and development. Our Public Programmes team examine who is interested, who is not and why.
Read moreResearch and innovation news
Keep up-to-date with the latest news, publications and events from the Research and Innovation team at MFT.
How the use of brain imaging is furthering our understanding of Lupus
Michelle Baraclough is a researcher at NIHR Manchester Musculoskeletal Biomedical Research Unit. In this blog Michelle discusses her research into neurocognitive function in patients with lupus.
Read more
One hundred cancer patients a year in Manchester benefit from scan technology
Researchers in Manchester have used recent advances in PET scanning technology to reduce the radiation dose for both patients and staff by up to 30%, allowing an addition of an annual 100 scans a year
Read more
Platform for Investigation: More than just a number
A day of interactive and engaging activities to will help the public question, explore and share ideas on health data.
Read more
Susan’s story
Susan has lupus, an autoimmune disease where the body mistakenly attacks health tissue. She has been a patient at MRI for almost 20 years and has taken part in a number of different research studies.
Read more
Researchers in children’s health and PPD explore opportunities for joint working
Our Consultants presented summaries of their team’s clinical and research expertise, patient populations in particular disease areas, and their aspirations relating to potential clinical trials.
Read more
Manchester plays role in trial of new innovative drug for Huntington’s disease
The first few patients in London and Vancouver have received doses of an experimental RNA-targeting drug for Huntington’s disease, it was announced today.
Read more
New research investigates whether bacteria found on your skin and in your gut plays a role in developing psoriatic arthritis
New research led by Anne Barton, Professor of Rheumatology at The University Manchester, will investigate the role bacteria plays in the development and treatment of psoriatic arthritis (PsA).
Read more
